YCM
NBIX icon

Yousif Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Yousif Capital Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.88M Sell
28,979
-1,718
-6% -$255K 0.05% 320
2026
Q1 		$4.04M Sell
30,697
-1,349
-4% -$179K 0.05% 356
2025
Q4 		$4.31M Sell
32,046
-475
-1% -$68.8K 0.05% 361
2025
Q3 		$4.57M Sell
32,521
-2,206
-6% -$299K 0.05% 350
2025
Q2 		$4.36M Sell
34,727
-918
-3% -$105K 0.05% 362
2025
Q1 		$3.94M Sell
35,645
-1,398
-4% -$177K 0.05% 367
2024
Q4 		$5.06M Sell
37,043
-1,559
-4% -$193K 0.06% 318
2024
Q3 		$4.45M Sell
38,602
-4,903
-11% -$672K 0.05% 365
2024
Q2 		$5.99M Sell
43,505
-2,957
-6% -$406K 0.07% 273
2024
Q1 		$6.41M Sell
46,462
-346
-0.7% -$47.3K 0.07% 271
2023
Q4 		$6.17M Sell
46,808
-370
-0.8% -$42.6K 0.07% 268
2023
Q3 		$5.31M Sell
47,178
-2,555
-5% -$269K 0.07% 288
2023
Q2 		$4.69M Sell
49,733
-1,246
-2% -$122K 0.06% 336
2023
Q1 		$5.16M Buy
50,979
+180
+0.4% +$18.7K 0.07% 296
2022
Q4 		$6.07M Buy
50,799
+1,101
+2% +$129K 0.08% 245
2022
Q3 		$5.28M Sell
49,698
-4,584
-8% -$465K 0.08% 257
2022
Q2 		$5.29M Buy
54,282
+2,255
+4% +$208K 0.07% 275
2022
Q1 		$4.88M Buy
52,027
+1,657
+3% +$140K 0.05% 368
2021
Q4 		$4.29M Buy
+50,370
New +$4.63M 0.04% 462

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Yousif Capital Management's NBIX Position: Q2 2026 in Review

Yousif Capital Management reduced its Neurocrine Biosciences (NBIX) stake by 5.6% in Q2 2026, selling an estimated $255K and leaving 28,979 shares worth $4.88M. The position accounts for 0.05% of the portfolio, ranked #320.

Yousif Capital Management first reported a position in NBIX in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.41M in Q1 2024. 133 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Yousif Capital Management held 28,979 shares of Neurocrine Biosciences worth $4.88M as of Q2 2026.
  • Yousif Capital Management sold 1,718 Neurocrine Biosciences shares in Q2 2026, an estimated $255K.
  • Neurocrine Biosciences made up 0.05% of Yousif Capital Management's portfolio in Q2 2026, its #320 holding.
  • Yousif Capital Management first reported a position in Neurocrine Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Neurocrine Biosciences position peaked at $6.41M in Q1 2024.
  • 133 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.